Drug Discovery Innovation Programme (DDIP)’s cover photo
Drug Discovery Innovation Programme (DDIP)

Drug Discovery Innovation Programme (DDIP)

Biotechnology Research

Drug Discovery Innovation Programme, 29-30 September 2026, Movenpick, Basel, Switzerland

About us

The Drug Discovery Innovation Programme (DDIP) is a leading platform bringing together pharma, biotech, and research leaders to explore the breakthroughs redefining R&D. With rising complexity, tighter timelines, and higher costs, discovery demands smarter strategies and new tools. DDIP focuses on the innovations driving this transformation, from AI-powered discovery platforms and biomarker-driven precision medicine to translational models that reduce failure rates and speed therapies to patients. The Programme emphasizes real-world applications, showcasing how collaboration across academia, biotech, and pharma can de-risk pipelines and accelerate progress. Beyond content, DDIP offers unparalleled networking and knowledge exchange, connecting decision-makers, startups, and researchers committed to advancing discovery science. More than an event, DDIP is a movement to transform challenges into opportunities and shape the future of therapies through innovation and collaboration.

Website
https://worldbigroup.com/Drug-Discovery-Conferences
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Office 7, 35-37 Ludgate Hill, London. EC4M 7JN

Updates

Affiliated pages

Similar pages